Preventing Progression To FEP
Preventing Progression To FEP
Preventing Progression To FEP
Background
Young people with self-experienced cognitive thought and number: NCT00204087). Primary outcome was progression to
perception deficits (basic symptoms) may present with an psychosis at 12- and 24-month follow-up.
early initial prodromal state (EIPS) of psychosis in which most
of the disability and neurobiological deficits of schizophrenia Results
have not yet occurred. A total of 128 help-seeking out-patients in an EIPS were
randomised. Integrated psychological intervention was
Aims superior to supportive counselling in preventing progression
To investigate the effects of an integrated psychological to psychosis at 12-month follow-up (3.2% v. 16.9%; P = 0.008)
intervention (IPI), combining individual cognitive–behavioural and at 24-month follow-up (6.3% v. 20.0%; P = 0.019).
therapy, group skills training, cognitive remediation and Conclusions
multifamily psychoeducation, on the prevention of psychosis Integrated psychological intervention appears effective in
in the EIPS. delaying the onset of psychosis over a 24-month time period
in people in an EIPS.
Method
A randomised controlled, multicentre, parallel group trial of Declaration of interest
12 months of IPI v. supportive counselling (trial registration None.
Early detection and intervention strategies have led to substantial basic symptoms (n = 160)15 indicate that the 12-month conversion
improvement in the prognosis of a number of non-psychiatric rate to psychosis is lower (19%) and the long-term conversion rate
medical conditions.1–3 The chronicity of schizophrenia provides higher (70% after 5.4 years) than the 12-month transition rate
the primary rationale for adapting these strategies for schizo- of the ultra-high-risk population (20–30%).4–6 Moreover, cross-
phrenia. In recent years, criteria based on subthreshold levels of sectional data indicate that levels of psychopathological
psychotic symptoms (ultra-high-risk criteria) have been found symptoms, disability, neurophysiological and neuropsychological
to predict psychosis onset within 12 months in 20–30% of deficits are lower in patients with basic symptoms than in patients
cases.4–6 This approach has provided the opportunity of indicated who fulfil ultra-high-risk criteria.17–19 Therefore, it has been
prevention efforts in individuals at imminent risk of schizo- hypothesised that people with basic symptoms might be in an
phrenia in order to reduce or prevent the devastating effects of early initial prodromal state (EIPS) of psychosis in which
the disorder.7 symptoms, disability and biological deficits are less severe than
Five randomised controlled trials (RCTs) in the ultra-high-risk in the ultra-high-risk population, and that the EIPS population
population have been completed so far. They have included may therefore be more responsive to preventive interventions than
evaluations of low-dose risperidone and cognitive–behavioural people who already fulfil ultra-high-risk criteria.20,21
therapy (CBT) combined,8 CBT alone,9,10 olanzapine alone11 However, to date, no information on the efficacy of inter-
and omega-3 fatty acids.12 Although the results of the treatment ventions in people in the EIPS is available. Therefore, the present
phase were statistically borderline10,11 or significant8,9,12 in favour RCT study has been undertaken to test the efficacy of a specifically
of the respective experimental condition, these effects were not devised integrated psychological intervention (IPI) compared with
sustained at 12-,8 24-11 or 36-month13,14 follow-up. The increased supportive counselling in individuals in an EIPS. Integrated
rate of conversion and return of prodromal symptoms to psychological intervention consists of individual CBT, modified
significantly higher levels after removing the specific intervention social skills training, cognitive remediation and multifamily
led some authors to conclude that interventions in the ultra-high- psychoeducation. It was chosen as the experimental condition
risk population merely delay conversion to psychosis rather than because (a) the applied strategies have been found to be effective
prevent it.11 in individuals at ultra-high risk and patients with psychosis;8–10,22–24
One of the reasons for the limited efficacy of indicated (b) there is no risk of exposing false positives to possible
prevention efforts might be that individuals who meet ultra-high- pharmacological side-effects; and (c) it is an established treatment
risk criteria already present with symptoms similar to psychotic for anxiety, depression and several other syndromes which are
symptoms. Thus, in the ultra-high-risk population most of the regularly present in the pre-psychotic phase.25,26 Supportive
symptoms, disability and neurobiological deficits associated with counselling was designed to provide a minimal level of support
schizophrenia might already be present15. However, certain subtle, for individuals who were seeking help and clearly in need of
self-experienced thought and perception deficits (basic symptoms) support as a result of psychiatric symptoms or concerns relating
have been described in initial prodromal states of schizophrenia, to functional domains.
which may precede the onset of subthreshold psychotic This paper presents the 12-month (post-treatment) and
symptoms.15,16 Furthermore, prospective data of people with 24-month follow-up results of the RCT. The primary outcome
22
Integrated psychological intervention for the prevention of psychosis
23
Bechdolf et al
Table 1 Integrated psychological intervention for patients in an early initial prodromal state of psychosis
Module Topics
Applied cognitive and behavioural strategies in individual and group therapy: formulation; collaborative goal-setting; provision of information and education about stress; basic
(Appendix 1) and negative symptoms, depression, anxiety; stress monitoring, relaxation, distraction techniques; self-monitoring of symptoms, thought monitoring, cognitive
restructuring, positive coping, positive reframing and challenging, goal-setting and time management; coping enhancement techniques, normalising self-experience of
neuropsychological deficits, behavioural strategies such as thought stopping, distraction, activity scheduling; exposure techniques; cognitive restructuring of negative and
self-defeating cognitions; relapse prevention; scheduling and monitoring of mastery and pleasure activities, keeping-well strategies, assertiveness and social skills training;
problem-solving.
It was computerised and based on cognitive exercises from the interventions and model responses for the therapist. Additionally,
COGPACK software (Marker Software, Mannheim, Germany), a 80 pages of working material for patients were provided. Further
multimedia cognitive rehabilitation software designed for use with details of IPI and case examples are presented elsewhere.37,38 The
individuals with compromised brain functioning. In each session, feasibility of the intervention was tested and confirmed in a pilot
three to six tasks were performed, involving repeated practice of sample of 12 patients.39
exercises for attention, memory and executive functioning.
Patients received performance scores, which were recorded and
referred to in order to reinforce performance progress. Task Supportive counselling
parameters were initially made sufficiently easy for each patient The supportive counselling was designed to provide a minimal
to do well. After session 6, tasks were made more difficult, level of support for individuals who were seeking help and were
according to the next level of difficulty (low to medium, or clearly in need of support as a result of psychiatric symptoms or
medium to severe). concerns relating to functional domains. Basic assessment, basic
psychoeducation about the at-risk mental state and counselling
in a supportive, warm, genuine, empathic and unstructured style
Psychoeducational multifamily groups. In addition, psycho-
were delivered. Supportive counselling was delivered on a one-to-
educational multifamily groups for family members or key
one basis, manual based, regularly supervised and lasted for a
persons were offered. These groups provided information on
maximum of 30 sessions over 12 months.
symptoms, course and treatment of at-risk mental states, as
detailed in a manual.17,36 These sessions aimed to increase the
family’s understanding of the EIPS and to reduce stress and Assessments
interpersonal conflicts.
Face-to-face assessment of the development of the primary
outcomes – subthreshold psychotic symptoms, psychosis and
Procedures and manual. Integrated psychological intervention schizophrenia – were undertaken at each individual treatment
was initially commenced with individual CBT delivered weekly session (maximum of 30 assessments) during the treatment phase
or every 2 weeks, which was then consecutively supplemented and at post-treatment (month 12). During the post-treatment
by cognitive remediation and psychoeducation of family members phase, patients were regularly asked about the primary outcomes
or key persons. Following the assessment and engagement phase, by telephone and by face-to-face interview during the 24-month
and formulation and goal setting, group skills training was offered follow-up. If the telephone interview indicated a deterioration of
to participants, depending on availability of places in the group. symptoms and/or an increased risk of conversion, an additional
While participants were attending the weekly group sessions, the face-to-face interview was conducted. If patients did not attend
frequency of individual sessions was reduced to crisis intervention, assessments, every effort was made to follow them up and to
and only maintained in individuals who were clinically judged to complete assessments with regard to primary outcome variables
have a particularly high risk of developing psychosis or dropping by means of telephone calls and home assessments. If patients
out. During the treatment phase of individual CBT, before or after were not available for interviews, key persons and hospital
the group intervention, CBT sessions were planned to be weekly, admission data were approached to determine conversion status.
with a reduction in their frequency during the termination phase Patients were classified as converters or non-converters by an
towards the end of the overall treatment at 12 months. However, independent consultant psychiatrist or senior clinical psychologist.
the frequency and duration of sessions were intended to be The masking of these independent consultant psychiatrists or
flexible, depending on arrangements made between patients and clinical psychologists was not formally measured.
therapists, as well as being contingent on the mental state of Basic symptom inclusion criteria (Appendix 1) were assessed
individual patients. in a semi-structured interview by a short version of the symptom
The IPI was detailed in a manual of 137 pages36,37 including an list of the ERIraos and the IROAS.27 Inclusion criteria were
overall treatment model, aims of the treatment components and operationally defined as fulfilled if one of the ten basic symptoms
sessions, problem-specific treatment modules, examples of was rated with a severity of at least 1 (corresponding to a mild
24
Integrated psychological intervention for the prevention of psychosis
severity). A basic symptom total score was calculated by summing (PANSS).42 In accordance with previous definitions8,9 the
the scores of the ten basic symptom items defining the EIPS.15 presence of brief limited intermittent psychotic symptoms or
Genetic risk of schizophrenia as part of the decreased functioning psychosis were operationally defined by cut-off points on PANSS
and risk factor criteria was assessed by the IRAOS.40 Obstetric subscales of 4 or more on hallucinations, 4 or more on delusions
complications were assessed by the respective ERIraos module, and 5 or more on conceptual disorganisation or formal thought
which was modelled on the Obstetric Complications, Scale (OCS).41 disorder. After meeting exit criteria, patients were classified by
The exit criteria to subthreshold psychosis and psychosis an independent consultant psychiatrist or senior clinical
(Appendix DS1) were defined in accordance with definitions used psychologist into one of three categories: (1) subthreshold
by RCTs in the ultra-high-risk population.8-12 The exit criteria to psychotic symptoms (see online Appendix DS1 for definitions);
the subthreshold psychosis syndrome ‘attenuated psychotic (2) DSM-IV psychosis diagnosis:43 schizophrenia/schizophreniform,
symptoms’ were assessed using the symptom list of the ERIraos, schizoaffective disorder, major depression with psychotic features,
and were operationally defined as fulfilled if one of the symptoms bipolar disorder with psychotic features, delusional disorder, brief
was rated as present. The subthreshold psychosis syndrome ‘brief psychotic disorder, brief psychotic disorder not otherwise
limited intermittent psychotic symptoms’ and psychosis criteria specified; or (3) DSM-IV schizophrenia/schizophreniform
were assessed by the Positive and Negative Syndrome Scale disorder diagnosis.43
6
No checklist assessment performed (n = 22) Assessed witih inclusion criteria checklist
7 (n = 1348)
6 6
Allocated to IPI (n = 63) Allocated to supportive counselling (n = 65)
Did not receive allocated intervention (n = 2) Did not receive allocated intervention (n = 1)
Attended no session (n = 2) Attended no session (n = 1)
Received allocated intervention (n = 61) Received allocated intervention (n = 64)
Received 450% of the intervention (n = 41) Received 450% of the intervention (n = 42)
Received 550% of the intervention (n = 20) Received 550% of the intervention (n = 22)
6 6
Completed 12-month follow-up (n = 51)
Withdrawn from intervention because of suspicion Completed 12-month follow-up (n = 57)
of organic brain disease (n = 1) Lost to follow-up (n = 8)
Lost to follow-up (n = 11) Moved (n = 3)
Moved (n = 1) Did not return (n = 5)
Did not return (n = 10)
6 6
Completed 24-month follow-up (n = 40) Completed 24-month follow-up (n = 41)
Lost to follow-up (n = 11) Lost to follow-up (n = 16)
Moved (n = 2) Moved (n = 4)
Did not return (n = 9) Did not return (n = 12)
6 6
Analysed (n = 62) Analysed (n = 65)
25
Bechdolf et al
All assessors were experienced clinical psychologists or Table 2 Sample characteristics ( n = 128)
psychiatrists. They attended a comprehensive workshop lasting
Integrated
several days when the study commenced and yearly throughout psychological Supportive
the study. Reliability checks of the assessments were performed intervention counselling
three times throughout the study with a total number of nine (n = 63) (n = 65)
raters. Agreement with a gold standard rating on absence or
Age, years: mean (s.d.) 25.2 (5.4) 26.8 (6.2)
presence of a symptom from the ERIraos symptom list among
Male, n (%) 39 (61.9) 42 (64.6)
eight raters, who were sufficiently trained in the use of the
Met basic symptoma criteria, n (%) 59 (93.7) 64 (98.5)
schedule, were good to excellent44 (kappa 0.64–0.77). However,
Met decreased functioning and risk
one rater, who was still in need of further training, only achieved
factora criteria, n (%) 14 (22.2) 21(32.3)
a kappa of 0.49 (for symptoms present at time of the interview).
Marital status, n (%)
The reliabilities of the change assessments by the nine raters were
Married/cohabiting 28 (44.4) 24 (36.9)
good to excellent (kappa 0.63-0.87). Living alone/divorced 35 (55.6) 41 (63.1)
Employment status, n (%)
Statistical analysis Full/part time 11 (17.5) 16 (24.6)
Student/training 34 (54.0) 27 (41.5)
Kaplan–Meier survival analysis assessed differences in time to Unemployed/other 18 (28.6) 22 (33.8)
conversion to subthreshold psychotic symptoms between the
Housing status,b n (%)
two treatment arms over the 24-month follow-up using the log- Independent 40 (69.0) 18 (31.0)
rank test. Estimated survival rates were compared at the 12-month Primary family 49 (76.6) 15 (23.4)
and 24-month points on the survival curve using z-tests. Cox Baseline severity of symptomsc
regression was applied to assess whether the effects of treatment Prodromal symptoms (basic
on survival time remained constant when the impact of the basic symptom total score), mean (s.d.) 4.1 (3.1) 5.1 (3.4)
symptom total score at baseline was accounted for. These primary PANSS subscale score, mean (s.d.)
Positive 9.4 (2.9) 9.2 (2.1)
survival analyses were performed on all available follow-up data.
Negative 11.2 (4.1) 11.1 (4.1)
At 12-month and 24-month follow-up, a w2-test was used to General 28.2 (6.4) 28.8 (6.4)
calculate the difference in proportions of patients who developed MADRS score, mean (s.d.) 19.3 (7.8) 18.9 (7.7)
subthreshold psychotic symptoms, psychosis, or schizophreniform/ Global Assessment of Functioning 58.7 (11.0) 60.0 (10.1)
schizophrenia disorders in the two treatments. The numbers
PANSS, Positive and Negative Syndrome Scale; MADRS, Montgomery–Åsberg
needed to treat (NNT) with CBT to prevent one participant Depression Rating Scale.
making a conversion were calculated by the reciprocal of the a. For definitions see Appendix 1.
b. Six people had other living arrangements.
absolute risk reduction.45 Two-tailed tests of significance were c. Symptom data are missing for 0–16 participants.
used in all analyses, with a set to 0.05.
26
Integrated psychological intervention for the prevention of psychosis
-----------------------------------
-----------------------------------
1.0 – the annual risk in the general population. A transition rate of
P = 0.008
IPI (n = 63)
17% in the first year during supportive treatment is in line with
P = 0.019
a 19% transition rate in the original naturalistic Cologne Early
Proportion of non-converters
0.9 –
Recognition study.15 In accordance with the aim of identifying
an especially early stage of the illness, 12-month transition rates
0.8 – SC (n = 65) to psychosis in the control condition were lower in our EIPS trial
than in RCTs which used ultra-high-risk criteria as inclusion
criteria (17% v. 22–38%).8–12
0.7 –
As regards acceptance of, and adherence to, offered
interventions, our trial is reasonably comparable with the
0.6 – psychological intervention trial in an ultra-high-risk population
by Morrison et al 9 (8.9% v. 2.8% refused treatment). This
contrasts with prevention efforts involving treatment with anti-
0.5 – psychotics in ultra-high-risk individuals, which have proven less
0 6 12 18 24 30 acceptable to patients (refusal rate of 35.9%8) and have
Months relatively low adherence rates (45.2%8 and 54.8%11). The data
on unwanted side-effects go along similar lines. There were no
Fig. 2 Kaplan–Meier estimates of the rate of progression to reports of side-effects in the psychotherapy studies (Morrison
subthreshold psychosis in patients assigned to integrated et al,9 Addington et al10 or our own study), but McGorry and
psychological intervention (IPI, n = 63) or supportive counselling colleagues8 reported some instances of rigour and sedation due
(SC, n = 65). to risperidone treatment. In the McGlashan et al trial11 weight,
Pre-specified z-test comparisons for the difference in the proportions converting to pulse rate and fatigue increased significantly (by 8.8 kg and
subthreshold psychosis at 12 months (P = 0.008) and 24 months (P = 0.019). 9.5 beats/min for weight and pulse rate respectively) in the
olanzapine compared with the placebo group. The acute treatment
effects of the IPI intervention in comparison with supportive
Cox regression model. At 24-month follow-up, significantly fewer counselling were statistically significant, which was not the case
patients in the IPI group than in the supportive counselling group in some trials of ultra-high-risk populations.10,11 Moreover, in
had developed psychosis (3.2% v. 15.4%; w2 = 5.614, d.f. = 1, contrast to the trials in ultra-high-risk populations,8–11,13,14 the
P = 0.018) or schizophrenia/ schizophreniform disorder (1.6% v. conversion rates did not increase substantially after removing
12.3%; P = 0.033). Details of the participants classified as making the specific intervention in the EIPS population. Both findings
conversion are shown in online Table DS1. The NNTs with IPI support the hypothesis that people in an EIPS might be more re-
to prevent one person making the conversion were 8 (95% sponsive to treatment than people in later stages of the prodromal
CI 4.0–8.5) for subthreshold psychotic symptoms, 9 (95% CI phase.20,21
4.6–42.6) for psychosis and 10 (95% CI 2.1–19.3) for
schizophrenia/schizophreniform disorder. The overall conversion
rates did not differ between centres (exact P = 0.785). Methodological considerations
First, the overall sample size doubles those of earlier trials8–12 and
Use of antidepressants the methodological quality of the trial using the Clinical Trial
Assessment Measure46 was high, which strengthens the validity
At intake, 17.5% (n = 11) of the IPI group and 20% (n = 13) of
of the findings. Second, no formal measures of therapists’
the supportive counselling group were being prescribed anti-
adherence to the manual were employed, nor did we use any
depressants. At 12 months, 9.5% of the IPI group and 10.8% of
formal assessments of therapists’ competence. However, we believe
the supportive counselling group and at 24 months, 15.0% of
that the internal validity of the interventions was high, because the
the IPI group and 9.75% of the supportive counselling group were
framework, setting and supervision differed between IPI and
being prescribed antidepressant medication. There were no
supportive counselling, and additionally, both interventions were
significant differences in antidepressant use between treatment
detailed in specific manuals. Third, face-to-face contact with
groups.
therapists within the trial was higher for patients in the IPI group
than for patients receiving supportive counselling. Fourth, since
Discussion
all participants received some sort of treatment (IPI or supportive
counselling) and there was no ‘no treatment’ condition, we cannot
To our knowledge, this is the first trial to evaluate a specific
rule out that participants might have improved without treatment.
prevention strategy in individuals putatively in an EIPS. In
Finally, since IPI covered a variety of psychological strategies, the
accordance with our hypothesis, the incidence of and time to
trial design did not allow assessment of the relative contribution of
conversion to subthreshold psychotic symptoms, psychosis and
the psychological strategies provided.
schizophrenia/schizophreniform disorder during a 12-month
treating period was significantly lower for patients who received
specially designed IPI than for those who were treated with Clinical consequences
supportive counselling. This significant difference was maintained
Despite the limitations mentioned above, the data presented
throughout the 24-month follow-up.
indicate that specifically developed IPI was effective for delaying
the onset of subthreshold, first-episode psychosis and
Comparison with earlier trials in individuals schizophrenia over a 24-month time period. Moreover, the very
at risk of developing first-episode psychosis small numbers of converters after termination of treatment raises
The present study confirms that EIPS criteria define a clinically the likelihood that interventions in the EIPS indeed prevent
symptomatic and functionally compromised population whose psychosis. Integrated psychological therapy was safe, well accepted
27
Bechdolf et al
and tolerated by patients, did not produce unpleasant side-effects (k) decrease in Global Assessment of Functioning score of at least
and might have been helpful in reducing false positives as well. The 30 points (within the past year) and at least one of the following
NNTs of 8 (subthreshold psychotic symptoms) and 9 (psychosis) decreases in functioning and risk factors:
(i) first-degree relative with a lifetime-diagnosis of schizophrenia
for IPI to prevent one conversion are clinically meaningful and
(ii) a schizophrenia-spectrum disorder
contrast with for example, NNTs between 71 and 171 (depending
(iii) pre- or perinatal complications.
on degree of illness) for the treatment of hypertension to prevent
one stroke.1 Thus, IPI has the potential to improve the prognosis
of many young people in an EIPS and could reduce the devastat- References
ing consequences of schizophrenia for the affected individuals,
their families and society. 1 Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH,
et al. Health outcomes associated with various antihypertensive therapies
used as first-line agents: a network meta-analysis. JAMA 2003; 289: 2534–44.
Andreas Bechdolf, MD, MSc, Department of Psychiatry and Psychotherapy,
University of Cologne, Germany, and Department of Psychiatry, University of 2 Peters AL, Davidson MB, Schriger DL, Hasselbald V. A clinical approach for
Melbourne and ORYGEN Research Centre, Melbourne, Australia; Michael Wagner, the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin
PhD, Bonn Early Recognition and Intervention Centre for Mental Crises – ZeBB,
levels. Meta-analysis research group on the diagnosis of diabetes using
Section of Experimental and Clinical Psychology, Department of Psychiatry and
Psychotherapy, University of Bonn, Germany; Stephan Ruhrmann, MD, Cologne glycosylated hemoglybin levels. JAMA 1996; 276: 1246–52.
Early Recognition and Intervention Centre for Mental Crises – FETZ, Department of 3 Adams EK, Breen N, Joski PJ. Impact of the National Breast and Cervical
Psychiatry and Psychotherapy, University of Cologne, Germany; Susan Harrigan,
Detection Program on mammography and pap test utilization among white,
MSc, Orygen Research Centre, University of Melbourne, Melbourne, Australia;
Hispanic, and African American women: 1996–2000. Cancer 2007; 109:
Verena Putzfeld, Cologne Early Recognition and Intervention Centre for Mental
Crises – FETZ, Department of Psychiatry and Psychotherapy, University of Cologne, 348–58.
Germany; Ralf Pukrop, PhD, ScMD, Section of Experimental and Clinical Psychology, 4 Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an
Department of Psychiatry and Psychotherapy, University of Cologne, Germany; Anke
ultra high-risk group: psychopathology and clinical features. Schizophr Res
Brockhaus-Dumke, MD, Department of Psychiatry and Psychotherapy, University of
Cologne, Germany; Julia Berning, Bonn Early Recognition and Intervention Centre 2004; 67: 131–42.
for Mental Crises – ZeBB, Department of Psychiatry and Psychotherapy, University of 5 Ruhrmann S, Schultze-Lutter F, Salokangas RK, Heinimaa M, Linszen D,
Bonn, Germany; Birgit Janssen, MD, Dusseldorf Early Recognition and Intervention
Dingemans P, et al. Prediction of psychosis in adolescents and young adults
Centre for Mental Crises – FEZ, Department of Psychiatry and Psychotherapy,
University of Dusseldorf, Germany; Petra Decker, BA, Ronald Bottlender, MD,
at high risk: results from the prospective European prediction of psychosis
Munich Early Recognition and Intervention Centre for Mental Crises – FETZ, study. Arch Gen Psychiatry 2010; 67: 241–51.
Department of Psychiatry and Psychotherapy, University of Munich, Germany; Kurt 6 Cannon TD, Cadenhead K, Conblatt B, Woods SW, Addington J, Walker E,
Maurer, PhD, Schizophrenia Research Unit, Central Institute of Mental Health,
et al. Prediction of psychosis in youth at high clinical risk: a multi-site
Mannheim, Germany; Hans-Jürgen Möller, MD, Department of Psychiatry and
Psychotherapy, University of Munich, Germany; Wolfgang Gaebel, MD, Department longitudinal study in North America. Arch Gen Psychiatry 2008; 65: 28–37.
of Psychiatry and Psychotherapy, University of Dusseldorf, Germany; Heinz Häfner, 7 McGorry PD, Yung AR, Phillips LJ. The ‘close-in’ or ultra high-risk model:
MD, PhD, Schizophrenia Research Unit, Central Institute of Mental Health, Mannheim,
a safe and effective strategy for research and clinical intervention in
Germany; Wolfgang Maier, MD, Department of Psychiatry and Psychotherapy,
University of Bonn, Germany; Joachim Klosterkötter, MD, Department of Psychiatry
prepsychotic mental disorder. Schizophr Bull 2003; 29: 771–90.
and Psychotherapy, University of Cologne, Germany 8 McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, et al.
Can first episode psychosis be delayed or prevented? A randomized
Correspondence: Andreas Bechdolf, MD, MSc, Associate Professor,
controlled trial of interventions during the prepsychotic phase of
Department of Psychiatry and Psychotherapy, University of Cologne, Kerpener
Str. 62, 50924 Cologne, Germany. Email: [email protected] schizophrenia and related psychosis. Arch Gen Psychiatry 2002; 59: 921–8.
9 Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, et al.
First received 21 Mar 2009, final revision 9 May 2011, accepted 16 Jun 2011
Cognitive therapy for the prevention of psychosis in people at ultra-high risk.
randomised controlled trial. Br J Psychiatry 2004; 185: 291–7.
10 Addington J, Epstein I, Liu L, French P, Boydell KM, Zipursky RB. A randomized
Funding controlled trial of cognitive behavioral therapy for individuals at clinical high
risk of psychosis. Schizophr Res 2011; 125: 54–61.
This study is part of the German Research Network on Schizophrenia funded by the
11 McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, et
German Federal Ministry for Education and Research (BMBF, grant 01 GI 9935). The
sponsor of the study had no role in study design, data collection, data analysis, data al. A randomized, double-blind trial of olanzapine versus placebo in patients
interpretation, or writing of the report. prodromally symptomatic for psychosis. Am J Psychiatry 2006 163: 790–9.
12 Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM,
Harrigan SM, et al. Long-chain omega-3 fatty acids for indicated prevention
Appendix 1 of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen
Psychiatry 2010; 67: 146–54.
Inclusion criteria (early initial prodromal state)
13 Morrison AP, French P, Parker S, Roberts M, Stevens H, Bentall RP, et al.
Self-experienced thought and perception deficits (basic symptoms): one Three year follow-up of a randomised controlled trial of cognitive therapy for
or more of the following basic symptoms in the past 3 months several the prevention of psychosis in people at ultra-high risk. Schizophr Bull 2007;
times a week: 33: 682–7.
14 Phillipps LJ, McGorry PD, Yuen HP, Ward J, Donovan K, Kelly D, et al. Medium
(a) thought interferences
term follow-up of a randomized controlled trial of interventions for young
(b) thought perseveration people at ultra high risk of psychosis. Shizophr Res 2007; 96: 25–33.
(e) disturbances of receptive language, either heard or read 16 Gross G, Huber G. Psychopathology of basic stages of schizophrenia in view
of formal thought disturbances. Psychopathology 1985; 18: 115–25.
(f) decreased ability to discriminate between ideas and perception,
17 Bechdolf A, Pukrop R, Köhn D, Tschinkel S, Schultze-Lutter F, Ruhrmann S,
fantasy and true memories
et al. Subjective quality of life in subjects at risk for first episode psychosis:
(g) unstable ideas of reference (subject centrism) a comparison with first episode schizophrenia patients and healthy controls.
Schizophr Res 2005; 79: 137–41.
(h) derealisation
18 Brockhaus-Dumke A, Ruhrmann S, Tendolkar I, Pukrop R, Klosterkötter J.
(i) visual perception disturbances (blurred vision, transitory blindness, Impaired mismatch negativity (MMN) generation in prodromal and
partial sight, hypersensitivity to light, etc.) schizophrenia patients. Schizophr Res 2005; 73: 297–310.
(j) acoustic perception disturbances (hypersensitivity to sounds or noise, 19 Pukrop R, Schultze-Lutter F, Ruhrmann S, Brockhaus-Dumke A, Tendolkar I,
acoasms, etc.) Bechdolf A, et al. Neurocognitive indicators for a transition to psychosis:
comparison of subjects at risk who transited to psychosis and who did not
and/or transit. Schizophrenia Res 2007; 92: 116–25.
28
Integrated psychological intervention for the prevention of psychosis
20 Bechdolf A, Ruhrmann S, Wagner M, Kühn KU, Janssen B, Bottlender R, et al. 34 Kingdon D, Turkington D. Cognitive-Behavioural Therapy for Schizophrenia.
Interventions in the initial prodromal states of psychosis in Germany: concept Lawrence Erlbaum, 1995.
and recruitment. Br J Psychiatry 2005; 187 (suppl 48): s45–8.
35 Beck AT. Cognitive Therapy and the Emotional Disorders. International
21 Häfner H, Maurer K, Ruhrmann S, Bechdolf A, Klosterkötter J, Wagner M, et al. University Press, 1976.
Are early detection and secondary prevention feasible? Facts and visions.
Eur Arch Psychiatry Clin Neurosci 2004; 254: 117–28. 36 Bechdolf A, Puetzfeld V, Gross S, Guettgemanns J. Cognitive Behavioural
Therapy in People at Risk of Psychosis. Huber, 2010.
22 Jones C, Cormac I, Silveira da Mota Neto JI, Campbell C. Cognitive behaviour
therapy for schizophrenia. Cochrane Database Syst Rev 2004; 4: CD000524. 37 Bechdolf A, Veith V, Klosterkötter J. Group intervention for people at high risk
of developing psychosis. In Working with People at Ultra-high Risk of
23 Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Orbach G, et al.
Developing Psychosis (eds J Addington, SH Francey, AP Morrison): 169–81.
Psychological treatment in schizophrenia: I. Meta-analysis of family
John Wiley & Sons, 2006.
intervention and cognitive behaviour therapy. Psychol Med 2002; 32: 763–82.
24 Penn DL, Waldheter EJ, Perkins DO, Mueser KT, Lieberman JA. Psychosocial 38 Bechdolf A, Phillips LJ, Francey S, Leicester S, Morrison AP, Veith V, et al.
treatment for first-episode psychosis. A research update. Am J Psychiatry Recent approaches to psychological interventions for people at risk of
2005; 162: 220–32. psychosis. European Arch Psychiatry Clin Neuroscience 2006: 256: 159–73.
25 Work Group on Panic Disorder, American Psychiatric Association. Practice 39 Bechdolf A, Veith V, Berning J, Stamm E, Janssen B, Wagner M, et al.
guideline for the treatment of patients with panic disorder. Am J Psychiatry Cognitive-behavioural therapy in the pre-psychotic phase. An exploratory
1998; 155 (suppl 5): 1–34. study. Psychiatr Res 2005; 136: 251–5.
26 American Psychiatric Association. Practice guideline for the treatment of 40 Häfner H, Riecher-Rössler A, Hambrecht M, Maurer K, Meissner S, Schmidtke
patients with major depressive disorder (revision). Am J Psychiatry 2000; 157 A, et al. IRAOS: an instrument for the assessment of onset and early course
(suppl 4): 1–45. of schizophrenia. Schizophr Res 1992; 6: 209–23.
27 Haefner H, Bechdolf A, Klosterkötter J, Maurer K. Early Detection and 41 Lewis SW, Murray RM. Obstetric complications, neurodevelopment deviance
Intervention in Psychosis. A Practise Handbook. Schattauer, 2011. and risk of schizophrenia. J Psychiatr Res 1987; 21: 413–21.
28 Cannon M, Jones PB, Murray RM. Obstetric complications and schizophrenia:
42 Kay SR, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for
historical and meta-analysis. Am J Psychiatry 2002; 159: 1080–92.
schizophrenia. Schizophr Bull 1987; 13: 507–18.
29 Geddes JR, Lawrie SM. Obstetric complications and schizophrenia: a meta-
analysis. Br J Psychiatry 1995; 167: 786–93. 43 American Psychiatric Association. Diagnostic and Statistical Manual of
Mental Disorders (Fourth Edition) (DSM-IV). APA, 1994.
30 Nuechterlein KH, Dawson ME. A heuristic vulnerability/stress model of
schizophrenic episodes. Schizophr Bull 1984; 10: 300–12. 44 Cicchetti DV, Sparrow SA. Developing criteria for establishing interrater
reliability of specific items: applications to assessment of adaptive behaviour.
31 Larsen TK, Bechdolf A, Birchwood M. The concept of schizophrenia and
Am J Ment Defic 1981; 86: 127–37.
phase specific treatment. Psychological treatment in pre-psychosis and non-
responders. J Am Acad Psychoanal Dyn Psychiatry 2003; 31: 209–28. 45 Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure
32 Chadwick PDJ, Birchwood M, Trower P. Cognitive Therapy for Delusions, of treatment effect. BMJ 1995; 310: 452–4.
Voices and Paranoia. John Wiley & Sons, 1996. 46 Tarrier N, Wykes T. Is there evidence that cognitive behaviour therapy is an
33 Fowler D, Garety P, Kuipers E. Cognitive Behaviour Therapy for People with effective treatment for schizophrenia? A cautious or cautionary tale? Behav
Psychosis. John Wiley & Sons, 1995. Res Ther 2004; 42: 1377–401.
29
The British Journal of Psychiatry
1–2. doi: 10.1192/bjp.bp.109.066357
Online supplement
Appendix DS1
Exclusion criteria
(a) Attenuated or brief limited intermittent psychotic symptoms
(b) Present or past diagnosis of a schizophrenic, schizophreniform,
schizoaffective, delusional or bipolar disorder according to DSM-IV
(c) Present or past diagnosis of a brief psychotic disorder according to
DSM-IV with a duration of more than 1 week or within the past 4
weeks regardless of its duration
(d) Diagnosis of delirium, dementia, amnestic or other cognitive disorder,
mental retardation, psychiatric disorders due to a somatic factor or
related to the consumption of psychotropic substances according to
DSM-IV
(e) Alcohol or drug dependence within the past 3 months according to
DSM-IV
(f) Organic brain disease (inflammatory, traumatic, epilepsy, etc.)
(g) Previous treatment with antipsychotics
(h) Acute suicidality
(i) Aged below 17 and above 35 years.
Exit criteria
Subthreshold psychotic symptoms
1
Table DS1 Details of participants classified as converting to subthreshold psychosis
Time to conversion,
Participant Age, years Gender Entry route Allocation months Probable DSM-IV psychosis diagnosisa
1 19 Male BS SC 5 Schizophrenia/schizophreniform
2 18 Female BS SC 2 Schizophrenia/schizophreniform
3 35 Male BS+DF/R IPT 7 None
4 19 Male BS+DF/R SC 11 Schizophrenia/schizophreniform
5 19 Male BS+DF/R SC 11 Schizophrenia/schizophreniform
6 18 Male BS SC 2 Schizophrenia/schizophreniform
7 24 Male BS SC 3 None
8 22 Male BS SC 3 Psychosis
9 18 Male BS SC 3 Schizophrenia/schizophreniform
10 18 Female BS+DF/R SC 9 None
11 35 Female BS SC 1 Schizophrenia/schizophreniform
12 18 Male BS IPT 11 None
13 20 Male BS SC 8 Schizophrenia/schizophreniform
14 23 Male BS SC 13 None
15 31 Female BS SC 16 Psychosis
16 22 Male BS+DF/R IPT 18 None
17 18 Male BS+DF/R IPT 22 Schizophrenia/schizophreniform
BS, basic symptoms (for definitions see Appendix 1); DF/R, decrease in functioning and risk factors (for definitions see Appendix 1); SC, supportive counselling; IPT, integrated
psychological therapy.
a. None: subthreshold psychotic symptoms (attenuated psychotic symptoms, brief limited psychotic symptoms; see Appendix 1 for definitions); psychosis: DSM-IV
psychotic diagnosis (schizophrenia/schizophreniform, schizoaffective disorder, major depression with psychotic features, bipolar disorder with psychotic features, delusional disorder,
brief psychotic disorder, brief psychotic disorder not otherwise specified); schizophrenia/schizophreniform: probable DSM-IV schizophrenia/schizophreniform disorder diagnosis.
2
Preventing progression to first-episode psychosis in early initial
prodromal states
Andreas Bechdolf, Michael Wagner, Stephan Ruhrmann, Susan Harrigan, Verena Putzfeld, Ralf Pukrop,
Anke Brockhaus-Dumke, Julia Berning, Birgit Janssen, Petra Decker, Ronald Bottlender, Kurt Maurer,
Hans-Jürgen Möller, Wolfgang Gaebel, Heinz Häfner, Wolfgang Maier and Joachim Klosterkötter
BJP 2012, 200:22-29.
Access the most recent version at DOI: 10.1192/bjp.bp.109.066357
References This article cites 38 articles, 7 of which you can access for free at:
http://bjp.rcpsych.org/content/200/1/22#BIBL
Reprints/ To obtain reprints or permission to reproduce material from this paper, please
permissions write to [email protected]